Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A.
Parth VashiKatharine BattRobert KlamrothMaria Elisa MancusoRenata MajewskaAndreas TiedeLorenzo Giovanni MantovaniPublished in: Journal of blood medicine (2021)
BAY 94-9027 prophylaxis demonstrated 26.7% lower annual consumption when compared to N8-GP with similar efficacy in terms of ABR and percentage of patients with zero bleeds.
Keyphrases